how big is Gujarat Alkalies?

As of Jun 06, Gujarat Alkalies & Chemicals Ltd has a market capitalization of 4,318.09 Cr, with recent net sales of 4,072.91 Cr and a net profit of -65.12 Cr. Shareholder's funds are valued at 6,075.54 Cr, and total assets amount to 8,023.39 Cr.

Market Cap: As of Jun 06, Gujarat Alkalies & Chemicals Ltd has a market capitalization of 4,318.09 Cr, categorizing it as a Small Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters, the company reported a sum of Net Sales amounting to 4,072.91 Cr and a sum of Net Profit of -65.12 Cr. This data is on a Consolidated basis.<BR><BR>Balance Sheet Snapshot: This is also on a Consolidated basis for the latest annual period ending in Mar'24. The Shareholder's Funds are valued at 6,075.54 Cr, while the Total Assets amount to 8,023.39 Cr.

Who are in the management team of Gujarat Alkalies?

As of March 2023, the management team of Gujarat Alkalies includes Sanjay S Bhatt (Company Secretary), Swaroop P (Managing Director), Hasmukh Adhia (Chairman), and several independent directors, ensuring effective governance and management.

As of March 2023, the management team of Gujarat Alkalies includes the following individuals:<BR><BR>1. Sanjay S Bhatt - Company Secretary & Compliance Officer<BR>2. Rajiv Lochan Jain - Independent Director<BR>3. S B Dangayach - Independent Director<BR>4. Jagdish Prasad Gupta - Executive Director<BR>5. Nitin Shukla - Independent Director<BR>6. Shridevi Shukla - Independent Director<BR>7. Swaroop P - Managing Director<BR>8. Hasmukh Adhia - Chairman (Non-Executive)<BR>9. Rahul B Gupta - Additional Director<BR>10. Jorg Nohl - Additional Director<BR><BR>This team comprises a mix of executive and independent directors, contributing to the governance and management of the company.

Has Gujarat Alkalies declared dividend?

Yes, Gujarat Alkalies & Chemicals Ltd has declared a 138% dividend, amounting to ₹13.8 per share, with an ex-date of September 19, 2024. While the company shows strong total returns over the 4- and 5-year periods, recent performance has been mixed, with negative returns in the shorter terms.

Gujarat Alkalies & Chemicals Ltd has declared a 138% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 138%<BR>- Amount per share: 13.8<BR>- Ex-date: 19 Sep 24<BR><BR>Dividend Yield: 2.33%.<BR><BR>Total Returns by Period:<BR>Over the last 6 months, the price return was -25.33%, with no dividend return, resulting in a total return of -25.33%.<BR><BR>In the past year, the price return was -18.05%, with a dividend return of 1.80%, leading to a total return of -16.25%.<BR><BR>Over the last 2 years, the price return was -9.22%, with a dividend return of 5.48%, resulting in a total return of -3.74%.<BR><BR>In the last 3 years, the price return was -26.79%, while the dividend return was 7.13%, culminating in a total return of -19.66%.<BR><BR>For the 4-year period, the price return was 46.51%, with a dividend return of 13.59%, yielding a total return of 60.1%.<BR><BR>Over the last 5 years, the price return was 77.67%, and the dividend return was 19.31%, resulting in a total return of 96.98%.<BR><BR>Overall, while Gujarat Alkalies has declared a significant dividend, the total returns over various periods show a mix of negative and positive performance, particularly highlighting strong returns over the longer 4- and 5-year periods.

Who are the peers of the Gujarat Alkalies?

Gujarat Alkalies' peers include Tata Chemicals, Chemplast Sanmar, GHCL, and others, with varying management and growth risks. In terms of returns, India Glycols leads at 150.39%, while Gujarat Alkalies has the lowest at -25.63%.

Peers: The peers of Gujarat Alkalies are Tata Chemicals, Chemplast Sanmar, GHCL, India Glycols, Fischer Medical, Grauer & Weil, Tanfac Inds., Thirumalai Chem., Blue Pearl Agri, and J.G.Chemicals.<BR><BR>Quality Snapshot: Excellent management risk is observed at GHCL and Tanfac Inds., while Good management risk is found at Chemplast Sanmar and GHCL. Average management risk is present at Tata Chemicals, Grauer & Weil, Thirumalai Chem., and J.G.Chemicals, and Below Average management risk is noted at Gujarat Alkalies and Fischer Medical. In terms of Growth, Excellent growth is seen at Tanfac Inds., while Below Average growth is reported by Tata Chemicals, Chemplast Sanmar, GHCL, India Glycols, Thirumalai Chem., and Gujarat Alkalies. Average growth is noted at Fischer Medical, and the rest. Capital Structure is Excellent for Gujarat Alkalies, GHCL, and Tanfac Inds., while Average is found at Tata Chemicals, Grauer & Weil, and Thirumalai Chem., and Below Average at Chemplast Sanmar and India Glycols.<BR><BR>Return Snapshot: The peer with the highest 1-year return is India Glycols at 150.39%, while the lowest is Gujarat Alkalies at -25.63%. Compared to its peers, Gujarat Alkalies has a significantly lower return. Additionally, the peers with negative six-month returns include Tata Chemicals, Chemplast Sanmar, Gujarat Alkalies, Grauer & Weil, Thirumalai Chem., and Blue Pearl Agri.

What does Gujarat Alkalies do?

Gujarat Alkalies and Chemicals Ltd is a leading producer of Caustic Soda Lye in India, established in 1973, with a market cap of INR 4,360 Cr and reported net sales of 10,755 Cr and net profit of 88 Cr for Q1 2025. The company operates in the Commodity Chemicals industry and has a low debt-equity ratio of 0.07.

Overview:<BR>Gujarat Alkalies and Chemicals Ltd is one of the largest producers of Caustic Soda Lye in India, operating within the Commodity Chemicals industry and classified as a Small Cap company.<BR><BR>History:<BR>The company was incorporated in the year 1973. As of the latest quarter reported, which is March 2025, the company has reported net sales and profit figures.<BR><BR>Financial Snapshot:<BR>- Net Sales: 10,755 Cr (Quarterly Results - Mar 2025)<BR>- Net Profit: 88 Cr (Quarterly Results - Mar 2025)<BR>- Market Cap: INR 4,360 Cr (Small Cap)<BR><BR>Key Metrics:<BR>- P/E: N/A<BR>- Industry P/E: 47<BR>- Dividend Yield: 2.34%<BR>- Debt-Equity: 0.07<BR>- Return on Equity: -1.15%<BR>- Price to Book: 0.76<BR><BR>Contact Details:<BR>- Address: PO Petrochemicals, Vadodara Gujarat: 391346<BR>- Phone: 91-265-2232681-82/2232981-82/701<BR>- Email: investor_relations@gacl.co.in<BR>- Website: http://www.gacl.com

Who are the top shareholders of the Gujarat Alkalies?

The top shareholders of Gujarat Alkalies include Gujarat State Investments Limited with 20.87%, Lok Prakashan Ltd at 22.08%, five mutual fund schemes holding 2.68%, and 72 foreign institutional investors with a combined 1.71%. Individual investors own 16.26% of the company.

The top shareholders of Gujarat Alkalies include Gujarat State Investments Limited, which holds the highest promoter stake at 20.87%. Additionally, Lok Prakashan Ltd is the largest public shareholder with a holding of 22.08%. The company also has 5 mutual fund schemes collectively holding 2.68%, and 72 foreign institutional investors (FIIs) with a combined holding of 1.71%. Individual investors own 16.26% of the company.

When is the next results date for Gujarat Alkalies?

The next results date for Gujarat Alkalies is November 7, 2025.

The next results date for Gujarat Alkalies is scheduled for November 7, 2025.

Are Gujarat Alkalies latest results good or bad?

Gujarat Alkalies' latest results show a mixed outlook; while the company returned to profitability with a net profit of ₹16.34 crores, concerns arise from declining operating margins and a significant 33.92% drop in stock value over the past year, indicating ongoing operational challenges.

Gujarat Alkalies' latest results present a mixed picture, leaning more towards the negative side. While the company reported a net profit of ₹16.34 crores in Q2 FY26, a significant improvement from a loss of ₹13.78 crores in the previous quarter, the underlying operational metrics raise concerns.<BR><BR>The company's revenue grew by 9.33% year-on-year to ₹1,083.19 crores, but this was accompanied by a sequential decline of 1.98% from the previous quarter. More troubling is the operating margin, which fell to 6.82%, the lowest in recent quarters, highlighting ongoing challenges in maintaining profitability amid rising costs and competitive pressures.<BR><BR>Additionally, the stock has faced significant headwinds, with a decline of 33.92% over the past year, underperforming the broader market. The return on equity is notably low at just 3.85%, indicating inefficiencies in generating returns for shareholders.<BR><BR>In summary, while the return to profitability is a positive sign, the overall financial performance reflects persistent operational challenges and margin pressures, suggesting that the results are not particularly strong. Investors should be cautious and consider the broader context of the company's performance and market conditions.

Should I buy, sell or hold Gujarat Alkalies?

How has been the historical performance of Gujarat Alkalies?

Gujarat Alkalies' historical performance shows fluctuating net sales, peaking at 4,516.50 Cr in Mar'23 and declining to 4,072.91 Cr in Mar'25, with an operating profit of 360.42 Cr in Mar'25. Despite improvements in profit before tax and profit after tax, the consolidated net profit remained negative at -65.12 Cr.

Answer:<BR>The historical performance of Gujarat Alkalies shows a fluctuating trend in net sales, with figures reaching 4,072.91 Cr in Mar'25, up from 3,806.63 Cr in Mar'24, but down from 4,516.50 Cr in Mar'23. The total operating income mirrored this trend, reflecting similar values. The company's total expenditure increased to 3,712.49 Cr in Mar'25 from 3,670.60 Cr in Mar'24, leading to an operating profit (PBDIT) of 360.42 Cr, a significant rise from 136.03 Cr in the previous year. However, the profit before tax showed a stark decline to 9.72 Cr in Mar'25 from a loss of 195.88 Cr in Mar'24, while profit after tax improved to 15.82 Cr from a loss of 132.24 Cr. Despite these improvements, the consolidated net profit remained negative at -65.12 Cr in Mar'25, although it was an improvement from -236.84 Cr in Mar'24. The earnings per share (EPS) reflected this trend, showing -8.87 in Mar'25 compared to -32.25 in Mar'24.<BR><BR>Breakdown:<BR>Gujarat Alkalies experienced a volatile financial performance over the years, with net sales peaking at 4,516.50 Cr in Mar'23 before declining to 4,072.91 Cr in Mar'25. The total operating income followed a similar pattern, while total expenditure rose, resulting in an operating profit of 360.42 Cr in Mar'25, a notable increase from the previous year. The profit before tax turned positive at 9.72 Cr, contrasting with the significant loss of 195.88 Cr in Mar'24, and profit after tax also improved to 15.82 Cr. However, the consolidated net profit remained negative at -65.12 Cr, despite being less severe than the prior year's loss. The EPS showed a similar recovery trend, moving from -32.25 to -8.87, indicating some operational recovery, although the overall financial health remains challenged.

Is Gujarat Alkalies overvalued or undervalued?

As of November 10, 2025, Gujarat Alkalies is considered undervalued with a valuation grade shift to very attractive, reflected by a high PE ratio of 27029.69, a reasonable EV to EBITDA of 10.28, and a low Price to Book Value of 0.07, especially when compared to peers like Solar Industries and Godrej Industries, despite its year-to-date stock performance lagging behind the Sensex.

As of 10 November 2025, the valuation grade for Gujarat Alkalies has moved from very expensive to very attractive. This indicates a significant reassessment of the company's value, suggesting it is currently undervalued. Key ratios reflect this: the PE ratio stands at an extraordinarily high 27029.69, while the EV to EBITDA is a more reasonable 10.28, and the Price to Book Value is notably low at 0.07.<BR><BR>In comparison to peers, Gujarat Alkalies appears to be in a favorable position despite its high PE ratio. For instance, Solar Industries has a PE of 96.11 and an EV to EBITDA of 59.13, while Godrej Industries shows a PE of 35.42 and an EV to EBITDA of 28.71. These comparisons further support the conclusion that Gujarat Alkalies is undervalued relative to its peers. Additionally, the company's recent stock performance has lagged behind the Sensex, with a year-to-date return of -26.40% compared to the Sensex's 6.91%, reinforcing the notion that it may be undervalued in the current market.

Is Gujarat Alkalies technically bullish or bearish?

As of November 10, 2025, Gujarat Alkalies shows a bearish trend with moderate strength, indicated by bearish daily moving averages and Bollinger Bands, despite mixed signals from the MACD and KST.

As of 10 November 2025, the technical trend has changed from mildly bearish to bearish. The current technical stance for Gujarat Alkalies is bearish with moderate strength. Key indicators driving this stance include the bearish signals from the daily moving averages and the Bollinger Bands on both weekly and monthly time frames. The MACD shows a mildly bullish signal on the weekly chart but remains bearish on the monthly, which adds to the mixed signals. The KST also reflects a mildly bullish stance on the weekly but is bearish on the monthly, indicating a lack of strong upward momentum. Overall, the combination of these indicators suggests a bearish outlook for the stock.

Which are the latest news on Gujarat Alkalies?

Why is Gujarat Alkalies falling/rising?

As of 04-Dec, Gujarat Alkalies & Chemicals Ltd's stock is at 524.05, down 0.09%, with significant declines of 30.14% year-to-date and 34.06% over the past year, underperforming the Sensex. The stock is trading below all moving averages, indicating a downward trend, and faces negative sentiment due to poor financial performance and high valuation relative to peers.

As of 04-Dec, Gujarat Alkalies & Chemicals Ltd's stock price is falling, currently at 524.05, reflecting a change of -0.45 (-0.09%). The stock has shown a significant decline over various periods, with a year-to-date decrease of 30.14% and a one-year drop of 34.06%, both of which are considerably worse than the benchmark Sensex, which has gained 9.12% and 5.32% respectively in the same time frames.<BR><BR>Today's performance indicates that the stock is trading below its moving averages across all time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This suggests a continued downward trend. Furthermore, despite a notable increase in delivery volume by 193.06% compared to the 5-day average, the overall sentiment remains negative due to poor long-term growth prospects. The company has reported an annual operating profit decline of 65.17% over the last five years, and recent financial results have shown a significant drop in profit before tax, indicating ongoing financial struggles.<BR><BR>Additionally, the stock's valuation appears expensive relative to its peers, with a Price to Book Value of 0.7 and a PEG ratio of 256.4, which further discourages investment. The company's return on equity stands at 0, highlighting a lack of profitability. Overall, the combination of underperformance against benchmarks, poor financial metrics, and high valuation relative to peers contributes to the stock's decline.